Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the efficacy of (SEROQUEL SR™ ) quetiapine
fumarate sustained-release (SR) compared to placebo in the treatment of anxiety symptoms in
patients with generalized anxiety disorder (GAD).
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation
was changed to XR after consultation with FDA.